DF Hayes

Abstract S1-7: Lack of Correlation between Gene Variants in Tamoxifen Metabolizing Enymes with Primary Endpoints in the ATAC Trial.

JM Rae, Suzanne Drury, DF Hayes et al. · Cancer Research · 2010 · 46 citations

Medicine, Pharmacology, Medical Genetics +15

Elevated CA125 levels in patients with metastatic breast carcinoma

Lucien Perey, DF Hayes, Carlo Tondini et al. · British Journal of Cancer · 1990 · 18 citations · Full text

Medicine, Oncology, Breast Oncology +12

Genetically determined polymorphism of the circulating human breast cancer-associated DF3 antigen

DF Hayes, Hiroshi Sekine, D. Marcus et al. · Blood · 1988 · 18 citations · Full text

Life Sciences, Genetics, Molecular Genetics +10

Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

JB Smerage, WE Barlow, DF Hayes et al. · Cancer Research · 2013 · 14 citations

Medicine, Oncology, Breast Oncology +14

S1-1: A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226.

Mehta Rs, WE Barlow, KS Albain et al. · Cancer Research · 2011 · 13 citations

Medicine, Oncology, Pharmacology +16